المؤلفون: Yun HY; Department of Pharmacy, College of Pharmacy, Chungnam National Universitygrid.254230.2, Daejeon, Republic of Korea., Chang MJ; Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Republic of Korea.; Department of Pharmaceutical Medicine and Regulatory Science, Yonsei University, Incheon, Republic of Korea.; Graduate Program of Industrial Pharmaceutical Science, Yonsei University, Incheon, Republic of Korea., Jung H; Department of Bio-AI Convergence, Chungnam National University, Daejeon, Republic of Korea., Chang V; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Wang Q; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Strydom N; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Yoon YR; Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.; Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea., Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Sep 20; Vol. 66 (9), pp. e0189321. Date of Electronic Publication: 2022 Aug 08.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Prothionamide*/therapeutic use , Tuberculosis, Multidrug-Resistant*/drug therapy, Adult ; Antitubercular Agents/adverse effects ; Humans

المؤلفون: Zheng X; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Gui X; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Yao L; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Ma J; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., He Y; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Lou H; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Gu J; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Ying R; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Chen L; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Sun Q; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Liu Y; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Ho CM; Department of Mechanical and Aerospace Engineering, University of California, Los Angeles, CA, USA.; Department of Bioengineering, University of California, Los Angeles, CA, USA., Lee BY; Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, CA, USA., Clemens DL; Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, CA, USA., Horwitz MA; Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, CA, USA., Ding X; Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, People's Republic of China., Hao X; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Yang H; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China., Sha W; Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China.

المصدر: Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2187247.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN: 2222-1751 (Electronic) Linking ISSN: 22221751 NLM ISO Abbreviation: Emerg Microbes Infect Subsets: MEDLINE

مواضيع طبية MeSH: Clofazimine*/adverse effects , Tuberculosis*/drug therapy, Humans ; Prothionamide ; Drug Therapy, Combination ; Antitubercular Agents/adverse effects ; Pyrazinamide/adverse effects ; Treatment Outcome ; Isoniazid

المؤلفون: Hasanuzzaman M; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea; Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali 3814, Bangladesh., Yi M; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea., Cho M; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea., Parvez MM; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea., Lee SJ; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea., Shin JG; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea. Electronic address: phshinjg@inje.ac.kr.

المصدر: Journal of pharmaceutical sciences [J Pharm Sci] 2019 Sep; Vol. 108 (9), pp. 3106-3111. Date of Electronic Publication: 2019 Apr 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6017 (Electronic) Linking ISSN: 00223549 NLM ISO Abbreviation: J Pharm Sci Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents/*pharmacology , Macrophages/*metabolism , Prothionamide/*pharmacokinetics , Rifampin/*pharmacology, ATP Binding Cassette Transporter, Subfamily B/metabolism ; Antitubercular Agents/therapeutic use ; Cell Line, Tumor ; Drug Antagonism ; Drug Resistance, Bacterial/drug effects ; Drug Therapy, Combination/adverse effects ; Humans ; Intracellular Fluid/metabolism ; Prothionamide/therapeutic use ; Rifampin/therapeutic use ; Tuberculosis/drug therapy ; Tuberculosis/microbiology ; Up-Regulation/drug effects

المؤلفون: Jiang H; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China., Li X; Department of Pharmacy, Guangzhou Chest Hospital, Guangzhou, China., Xing Z; Department of Pharmacy, Guangzhou Chest Hospital, Guangzhou, China., Niu Q; Pulmonary Disease Institute, Guangzhou Chest Hospital, Guangzhou, China., Xu J; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.

المصدر: Current drug delivery [Curr Drug Deliv] 2023; Vol. 20 (3), pp. 306-316.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101208455 Publication Model: Print Cited Medium: Internet ISSN: 1875-5704 (Electronic) Linking ISSN: 15672018 NLM ISO Abbreviation: Curr Drug Deliv Subsets: MEDLINE

مواضيع طبية MeSH: Mycobacterium tuberculosis* , Tuberculosis* , Tuberculosis, Multidrug-Resistant*/drug therapy , Tuberculosis, Multidrug-Resistant*/microbiology , Nanoparticles*, Humans ; Pyrazinamide/pharmacology ; Pyrazinamide/therapeutic use ; Prothionamide/pharmacology ; Prothionamide/therapeutic use ; Ethambutol/pharmacology ; Ethambutol/therapeutic use ; Levofloxacin/pharmacology ; Linezolid/pharmacology ; Linezolid/therapeutic use ; Reactive Oxygen Species ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Polylactic Acid-Polyglycolic Acid Copolymer/therapeutic use ; Antitubercular Agents

المؤلفون: Jeong HE; School of Pharmacy, Sungkyunkwan University, Suwon 16419, South Korea; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon 16149, South Korea., Choi J; School of Pharmacy, Sungkyunkwan University, Suwon 16419, South Korea., Oh IS; School of Pharmacy, Sungkyunkwan University, Suwon 16419, South Korea; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon 16149, South Korea., Son H; Department of Preventive Medicine, College of Medicine, Dong-A University, Busan 49201, South Korea., Jang SH; Division of Pulmonary, Allergy, and Critical Care Medicine, College of Medicine, Hallym University Sacred Heart Hospital, Hallym University, Anyang 14068, South Korea., Jung SY; College of Pharmacy, Chung-Ang University, Seoul 06974, South Korea., Shin JY; Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University, Seoul 06355, South Korea; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon 16149, South Korea. Electronic address: shin.jy@skku.edu.

المصدر: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2022 Oct; Vol. 55 (5), pp. 917-925. Date of Electronic Publication: 2021 Nov 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: published by Elsevier for the Taiwan Society of Microbiology Country of Publication: England NLM ID: 100956211 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1995-9133 (Electronic) Linking ISSN: 16841182 NLM ISO Abbreviation: J Microbiol Immunol Infect Subsets: MEDLINE

مواضيع طبية MeSH: Tuberculosis, Multidrug-Resistant*/drug therapy , Mycobacterium tuberculosis*, Humans ; Male ; Middle Aged ; Pyrazinamide/therapeutic use ; Prothionamide/therapeutic use ; Antitubercular Agents/pharmacology ; Streptomycin/therapeutic use ; Republic of Korea

المؤلفون: Chiwala G; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China; Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases, Guangzhou 510530, China; Guangzhou National Laboratory, Guangzhou 510320, China., Liu Z; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases, Guangzhou 510530, China., Mugweru JN; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China; Department of Biological Sciences, University of Embu, Embu 60100, Kenya., Wang B; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China., Khan SA; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China; Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases, Guangzhou 510530, China., Bate PNN; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China; Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases, Guangzhou 510530, China; Guangzhou National Laboratory, Guangzhou 510320, China., Yusuf B; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China; Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases, Guangzhou 510530, China; Guangzhou National Laboratory, Guangzhou 510320, China., Hameed HMA; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China; Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases, Guangzhou 510530, China; Guangzhou National Laboratory, Guangzhou 510320, China., Fang C; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China; Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases, Guangzhou 510530, China; Guangzhou National Laboratory, Guangzhou 510320, China., Tan Y; State Key Laboratory of Respiratory Disease, Guangzhou Chest Hospital, Guangzhou 510095, China., Guan P; State Key Laboratory of Respiratory Disease, Guangzhou Chest Hospital, Guangzhou 510095, China., Hu J; State Key Laboratory of Respiratory Disease, Guangzhou Chest Hospital, Guangzhou 510095, China., Tan S; State Key Laboratory of Respiratory Disease, Guangzhou Chest Hospital, Guangzhou 510095, China., Liu J; State Key Laboratory of Respiratory Disease, Guangzhou Chest Hospital, Guangzhou 510095, China., Zhong N; Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases, Guangzhou 510530, China; Guangzhou National Laboratory, Guangzhou 510320, China; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China., Zhang T; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China; Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases, Guangzhou 510530, China; Guangzhou National Laboratory, Guangzhou 510320, China. Electronic address: zhang_tianyu@gibh.ac.cn.

المصدر: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Oct; Vol. 142, pp. 112047. Date of Electronic Publication: 2021 Aug 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents/*pharmacology , BCG Vaccine/*immunology , Drug Resistance, Bacterial/*genetics , Mycobacterium bovis/*genetics , Mycobacterium tuberculosis/*drug effects , Tuberculosis, Pulmonary/*prevention & control , Vaccines, Synthetic/*immunology, Amikacin/pharmacology ; Amikacin/therapeutic use ; Animals ; Antigens, Bacterial/biosynthesis ; Antigens, Bacterial/genetics ; Antigens, Bacterial/immunology ; Antitubercular Agents/therapeutic use ; BCG Vaccine/biosynthesis ; BCG Vaccine/genetics ; BCG Vaccine/therapeutic use ; Disease Models, Animal ; Levofloxacin/pharmacology ; Levofloxacin/therapeutic use ; Mice, Inbred BALB C ; Mice, SCID ; Mycobacterium bovis/chemistry ; Mycobacterium bovis/drug effects ; Mycobacterium tuberculosis/pathogenicity ; Plasmids ; Prothionamide/pharmacology ; Prothionamide/therapeutic use ; Pyrazinamide/pharmacology ; Pyrazinamide/therapeutic use ; Tuberculosis, Pulmonary/drug therapy ; Tuberculosis, Pulmonary/pathology ; Vaccines, Synthetic/biosynthesis ; Vaccines, Synthetic/genetics ; Vaccines, Synthetic/therapeutic use ; Virulence ; Mice

المؤلفون: Baksam VK; Micro Labs Ltd, API R&D Centre, Bengaluru, Karnataka, India.; Department of Chemistry, JNTU Engineering College Kalikiri, Chitoor, Andhra Pradesh, India., Saritha N; Department of Chemistry, JNTU Engineering College Kalikiri, Chitoor, Andhra Pradesh, India., Mohan SK; Micro Labs Ltd, API R&D Centre, Bengaluru, Karnataka, India., Shandilya S; Micro Labs Ltd, API R&D Centre, Bengaluru, Karnataka, India., Kumar P; Micro Labs Ltd, API R&D Centre, Bengaluru, Karnataka, India.

المصدر: Journal of separation science [J Sep Sci] 2021 May; Vol. 44 (10), pp. 2078-2088. Date of Electronic Publication: 2021 Apr 09.

نوع المنشور: Evaluation Study; Journal Article

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101088554 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-9314 (Electronic) Linking ISSN: 16159306 NLM ISO Abbreviation: J Sep Sci Subsets: MEDLINE

مواضيع طبية MeSH: Chromatography, High Pressure Liquid/*methods , Magnetic Resonance Spectroscopy/*methods , Mass Spectrometry/*methods , Prothionamide/*chemistry, Drug Stability ; Hot Temperature ; Limit of Detection

المؤلفون: Thee S; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Department of Paediatric Pneumology and Immunology, Charité Universitätsmedizin Berlin, Germany. Electronic address: Stephanie.thee@charite.de., Garcia-Prats AJ; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Donald PR; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Hesseling AC; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Schaaf HS; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

المصدر: Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2016 Mar; Vol. 97, pp. 126-36. Date of Electronic Publication: 2015 Oct 19.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 100971555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-281X (Electronic) Linking ISSN: 14729792 NLM ISO Abbreviation: Tuberculosis (Edinb) Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents/*administration & dosage , Ethionamide/*administration & dosage , Mycobacterium tuberculosis/*drug effects , Prothionamide/*administration & dosage , Tuberculosis/*drug therapy, Adolescent ; Age Factors ; Animals ; Antitubercular Agents/adverse effects ; Antitubercular Agents/pharmacokinetics ; Child ; Child, Preschool ; Drug Compounding ; Drug Dosage Calculations ; Drug Resistance, Bacterial/genetics ; Ethionamide/adverse effects ; Ethionamide/pharmacokinetics ; Humans ; Infant ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/growth & development ; Prothionamide/adverse effects ; Prothionamide/pharmacokinetics ; Treatment Outcome ; Tuberculosis/diagnosis ; Tuberculosis/microbiology ; Young Adult

عنوان ترانسليتريتد: Dosis de protionamida y PAS. Corrección al «Documento de Consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis».

المؤلفون: García-García JM; Unidad de Gestión Clínica de Neumología, Hospital San Agustín, Avilés, Asturias, España. Electronic address: josemaria.garciag@sespa.es., González-Martín J; Servei de Microbiologia, Hospital Clínic-ISGLOBAL, Universitat de Barcelona, Barcelona, España.

مؤلفون مشاركون: Coordinadores del Consenso por parte de SEPAR y SEIMC, respectivamente, en nombre de todos los autores

المصدر: Enfermedades infecciosas y microbiologia clinica [Enferm Infecc Microbiol Clin] 2016 Aug-Sep; Vol. 34 (7), pp. 466. Date of Electronic Publication: 2015 Aug 19.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 9104081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-1852 (Electronic) Linking ISSN: 0213005X NLM ISO Abbreviation: Enferm Infecc Microbiol Clin Subsets: MEDLINE

مواضيع طبية MeSH: Prothionamide* , Tuberculosis*, Antitubercular Agents ; Consensus ; Humans

المؤلفون: Lee SH; Division of Pulmonary, Sleep, and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea., Seo KA; Department of Pharmacology and Pharmacogenomics Research Center, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea., Lee YM; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea., Lee HK; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea., Kim JH; Division of Pulmonary, Sleep, and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea., Shin C; Division of Pulmonary, Sleep, and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea., Ghim JR; Department of Pharmacology and Pharmacogenomics Research Center, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea., Shin JG; Department of Pharmacology and Pharmacogenomics Research Center, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea., Kim DH; Department of Pharmacology and Pharmacogenomics Research Center, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea. dhkim@inje.ac.kr.

المصدر: Yonsei medical journal [Yonsei Med J] 2015 Jul; Vol. 56 (4), pp. 961-7.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Yonsei University Country of Publication: Korea (South) NLM ID: 0414003 Publication Model: Print Cited Medium: Internet ISSN: 1976-2437 (Electronic) Linking ISSN: 05135796 NLM ISO Abbreviation: Yonsei Med J Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents/*pharmacokinetics , Cycloserine/*pharmacokinetics , Fluoroquinolones/*pharmacokinetics , Prothionamide/*pharmacokinetics , Sputum/*microbiology , Tuberculosis, Multidrug-Resistant/*drug therapy, Adult ; Aged ; Antitubercular Agents/blood ; Antitubercular Agents/therapeutic use ; Chromatography, High Pressure Liquid ; Cycloserine/blood ; Cycloserine/therapeutic use ; Fluoroquinolones/blood ; Fluoroquinolones/therapeutic use ; Humans ; Medication Adherence ; Middle Aged ; Moxifloxacin ; Prothionamide/blood ; Prothionamide/therapeutic use ; Retrospective Studies ; Tandem Mass Spectrometry ; Tuberculosis, Multidrug-Resistant/blood ; Young Adult